Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting.
Adolescent
Adult
Aged
Aged, 80 and over
Angioplasty, Balloon
/ adverse effects
Constriction, Pathologic
Female
Humans
Iliac Vein
/ diagnostic imaging
Male
May-Thurner Syndrome
/ diagnostic imaging
Middle Aged
Retrospective Studies
Severity of Illness Index
Stents
Time Factors
Treatment Outcome
Ultrasonography, Interventional
Vascular Patency
Young Adult
Iliac compression syndrome
Iliac vein stenting
Iliofemoral stenting
May-Thurner syndrome
Nonthrombotic iliac vein lesion
Journal
Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
04
06
2018
accepted:
01
10
2018
pubmed:
17
12
2018
medline:
5
3
2020
entrez:
17
12
2018
Statut:
ppublish
Résumé
May-Thurner syndrome (MTS) patients with lifestyle-limiting symptoms undergo stenting of the iliac vein for relief of compressive disease. The impact of degree of stenosis on clinical symptoms and outcomes after stenting is unknown and examined in our study. Retrospective review of contemporaneously entered data of 202 patients who underwent stenting for MTS between 2005 and 2011 was performed. Classification into three groups based on luminal area obtained by intraoperative intravascular ultrasound interrogation of the involved femoroiliocaval segments was carried out. Normal luminal diameters and areas were defined as 12 mm and 125 mm There were 55 patients who had mild, 87 patients who had moderate, and 60 patients who had severe iliac vein compression. Baseline demographic characteristics and comorbidities were similar across all groups. In addition, there was no statistically significant difference in median baseline visual analog scale score, grade of swelling, and VCSS among the groups. Compression was treated with angioplasty and stenting encompassing all areas of disease as determined by intravascular ultrasound. Stent technique involved use of Wallstent (Boston Scientific, Marlborough, Mass) only in 183 patients and Wallstent-Z stent (Cook Medical, Bloomington, Ind) combination in the remainder. No difference in median stent patency was noted on follow-up. Clinically, at 48 months, a statistically significant recurrence of pain, swelling, and worsening of VCSS were noted in the severe stenosis group but not in the other two groups. No variable was noted to have an impact on stent reintervention. Severity of MTS stenosis is not a predictor of initial clinical symptoms. Long term, patients with ≥90% initial MTS stenosis experience recurrence of symptoms. The degree of iliac venous stenosis does not appear to affect stent patency. Such information will help counsel patients before intervention.
Identifiants
pubmed: 30553783
pii: S2213-333X(18)30414-1
doi: 10.1016/j.jvsv.2018.10.001
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
195-202Informations de copyright
Copyright © 2018 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.